KELLIE ROSANBALM: Open Payments
NPI 1184015323 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,430 in 171 payments from 21 companies in 2025. Trend: 2023 $3,542 · 2024 $2,453 · 2025 $2,430
Food & beverage: $2,387Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 71 | $701 |
| PFIZER INC. | 41 | $367 |
| LivaNova USA, Inc. | 5 | $204 |
| Lilly USA, LLC | 14 | $189 |
| Lundbeck LLC | 7 | $181 |
| JAZZ PHARMACEUTICALS INC. | 9 | $156 |
| UCB, Inc. | 2 | $149 |
| Axsome Therapeutics, Inc. | 4 | $114 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
Products named: QULIPTA, NURTEC ODT, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, VYEPTI, UBRELVY, Zilbrysq, ZEPBOUND, EPIDIOLEX.
Industry payments across KY — which companies pay providers there.
